Amanote Research
Register
Sign In
Business Enterprise Expenditure for Pharmaceutical R&D (BERD) and Government Budgets for Health-Related R&D (GBARD), 2014 or Nearest Year
Health at a Glance 2017
doi 10.1787/health_glance-2017-graph184-en
Full Text
Open PDF
Abstract
Available in
full text
Date
November 10, 2017
Authors
Unknown
Publisher
OECD
Related search
R&D Intensity by Industry: Business Enterprise R&D Expenditure (BERD) as a Proportion of Gross Value Added (GVA), 2014 or Nearest Year
Health at a Glance 2017
Business R&D Performance by Size and Age, 2014
R&D Expenditure in Information Industries, 2013
Towards a Comprehensive R^|^amp;D Policy Package for the Japanese Pharmaceutical Industry
Iryo To Shakai
INCREMENTAL TAX CREDIT FOR R&D (LEGISLATIVE PROPOSALS)
RUDN Journal of Law
R&D Intensity by Industry, 2015
Energy R&D in the United States
European Commission Funding of Government and Higher Education R&D in Europe, 2015
Positions Open in the Investigation R^|^amp;D Committee
IEEJ Transactions on Industry Applications
Electronic Engineering
Industrial
Electrical
Manufacturing Engineering